Cancer

October 22, 2024
DeepHealth Strengthens AI Breast Cancer Screening Position with Kheiron Acquisition
October 17, 2024
Teal Health Receives $1.68M Grant for At-home Cervical Cancer Screening Device
October 16, 2024
FDA Approves Genentech’s Itovebi for Advanced Breast Cancer with PIK3CA Mutation
October 14, 2024
Menopause Scale-up Midi Health Launches Survivorship Program for Breast Cancer Survivors and At-Risk Women
October 11, 2024
Oxford Researchers Secure £600K Funding for World’s First Ovarian Cancer Prevention Vaccine
October 1, 2024
Cartherics Raises Over AU$15 Million to Advance Cell Therapy for Ovarian Cancer
October 1, 2024
FDA Approves Novartis’ Kisqali for Early Breast Cancer
September 19, 2024
DeepLook Medical Announces First Close of Series A Funding Round; Releases Promising Data on Cancer Detection Technology
September 19, 2024
Luminate Raises $15M to Revolutionize Cancer Care with Hair-Saving Chemo Helmet and Home Treatment Solutions
September 2, 2024
Melodi Health Secures $10.75M in Series A Funding; Enrolls First Patient in Pivotal Breast Reconstruction Trial
August 23, 2024
Medtech Company Cairn Surgical Secures $4.5M to Advance Breast Conserving Surgery
August 19, 2024
ENHERTU Receives Breakthrough Therapy Designation for Certain HER2 Low and Ultralow Metastatic Breast Cancer Patients
August 5, 2024
Noze Secures $5M Investment from Gates Foundation for Breath-based Disease Detection Technology
July 8, 2024
How Papcup is Advancing At-Home Cervical Cancer Screening with Menstrual Blood Testing
June 19, 2024
Sidekick Health Expands Oncology and Women’s Health Portfolio with Acquisition of PINK! in Germany
June 19, 2024
Mika Health, AstraZeneca, and Daiichi Sankyo Team Up to Provide AI-Enabled Support for Women with Breast Cancer
June 3, 2024
The Significance of Early HPV Diagnosis and Novel Screening Solutions
May 31, 2024
GC Aesthetics Introduces FixNip NRI, a New Solution for Breast Reconstruction
May 27, 2024
Lunit Acquires Volpara to Enhance AI-Driven Breast Cancer Screening and Diagnostics
May 21, 2024
BD and Roche Receive FDA Approval for Self-Collection Solutions for Cervical Cancer Screening
May 20, 2024
Amplexd Therapeutics Secures $2M to Advance HPV-Induced Cervical Precancer Treatments
May 8, 2024
Teal Health Receives FDA Breakthrough Designation for At-Home Cervical Cancer Screening Device
April 15, 2024
Bayer and Hologic Partner to Advance Breast Cancer Detection with Contrast-Enhanced Mammography
April 12, 2024
Roche Receives CE Mark for Companion Diagnostic Identifying Patients with HER2-Low Metastatic Breast Cancer Eligible for ENHERTU